Recruiting
Phase 1
Phase 2

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Sponsor:

Ellipses Pharma

Code:

NCT05443126

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EP0031

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information